Gemcitabine 1

Gemcitabine 1 g Injection
Gemcitabine 1 g Injection is a nucleoside analog antimetabolite anticancer drug used in the treatment of various solid tumors. It inhibits DNA synthesis in rapidly dividing cancer cells, thereby suppressing tumor growth. Gemcitabine is widely used as monotherapy or in combination chemotherapy regimens.
Product Details
Generic Name: Gemcitabine (as Gemcitabine Hydrochloride)
Strength: 1 g (1000 mg)
Dosage Form: Injection (Sterile lyophilized powder for reconstitution)
Route of Administration: Intravenous (IV infusion)
Therapeutic Class: Antimetabolite Anticancer Agent
Indications
Gemcitabine 1 g Injection is indicated for the treatment of:
Pancreatic cancer
Non-small cell lung cancer
Breast cancer
Ovarian cancer
Bladder cancer
Biliary tract cancers
Mechanism of Action
Gemcitabine is incorporated into DNA during replication and inhibits DNA synthesis, leading to apoptosis (programmed cell death) of cancer cells.
Key Benefits
Broad-spectrum efficacy against solid tumors
Widely used in combination chemotherapy regimens
Proven clinical safety and effectiveness
Accepted in global oncology treatment protocols
Dosage & Administration
Dosage and administration schedule are determined by the oncologist based on body surface area (BSA), cancer type, and patient condition. Administration should be performed only under strict medical supervision.
Storage Conditions
Store below 25°C
Protect from light
Do not freeze
Precautions
For hospital and oncology clinic use only
Regular monitoring of blood counts is required
Use with caution in patients with liver or kidney impairment